Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Open: 175.83 Close: 175.75 Change: -0.08
This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: Robert, CEO, Gonzalez, AbbVie, stock, Michael, July, and the …
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.
Robert Michael, AbbVies president and chief operating officer, will become CEO on July 1. Robert Michael will succeed Richard Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013.
Robert Michael, AbbVies president and chief operating officer, will become CEO on July 1. Robert Michael will succeed Richard Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013. Gonzalez, for his part, is retiring from the role after serving as CEO for 11 years to become executive chairman of the companys board. AbbVie Inc.s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday. He will be replaced by the companys current president and chief operating officer Robert Michael. AbbVie stock has received a consensus rating of buy. The 48 analysts offering price forecasts for Abbvie stock have a median target of 171.25, with a high estimate of 200.00 and a low estimate of 135.00. The high in the last 52 weeks was 178.92. According to the current price, Abvie is 99.01%. AbbVie announces 17 accepted abstracts for ECCO 2024, showcasing data on IBD treatments. Robert A. Gonzalez will retire as Abbvie CEO. AbbVies VYALEV™ (foslevodopa/foscarbidopa solution) Available for the Treatment of Advanced Parkinsons Disease in Canada. AGN.AX : 0.575 (+3.60%) ABBV : 175.75 (-0.98%) Robert Michael to succeed Richard Gonzalez as CEO, effective July 1. Cerevels research focuses on the brain and central nervous system, and its most advanced programs are directed at Parkinsons and schizophrenia. Karuna Therapeutics, which got snapped up by Bristol Myers Squibb just weeks after AbbVie and Cerevel inked their deal. AbbVie stock (NYSE: ABBV) stock price, news, charts, stock research, profile. abbvie (ABBV), quotes and news summary - benzinga.com. The next AbbBVie dividend date is projected to be Friday, April 12, 2024.
"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."
Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: Robert, CEO, Gonzalez, AbbVie, stock, Michael, July, and the most common words in the summary are: abbvie, stock, market, best, job, news, price, . One of the sentences in the summary was: Robert Michael, AbbVies president and chief operating officer, will become CEO on July 1. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #best #job #news #price.
Read more →Open: 179.84 Close: 177.88 Change: -1.96
Read more →Open: 182.19 Close: 180.57 Change: -1.62
Read more →Open: 174.78 Close: 176.75 Change: 1.97
Read more →Open: 174.46 Close: 173.29 Change: -1.17
Read more →Open: 169.42 Close: 168.67 Change: -0.75
Read more →Open: 165.27 Close: 164.4 Change: -0.87
Read more →Open: 165.27 Close: 164.17 Change: -1.1
Read more →Open: 161.75 Close: 162.04 Change: 0.29
Read more →Open: 161.75 Close: 162.04 Change: 0.29
Read more →Open: 164.25 Close: 163.78 Change: -0.47
Read more →Open: 154.54 Close: 154.97 Change: 0.43
Read more →Open: 154.05 Close: 154.51 Change: 0.46
Read more →Open: 152.05 Close: 152.59 Change: 0.54
Read more →Open: 154.74 Close: 154.04 Change: -0.7
Read more →Open: 144.79 Close: 146.38 Change: 1.59
Read more →Open: 140.0 Close: 138.67 Change: -1.33
Read more →Open: 141.89 Close: 141.2 Change: -0.69
Read more →Open: 141.89 Close: 141.2 Change: -0.69
Read more →Open: 138.77 Close: 137.27 Change: -1.5
Read more →Open: 148.95 Close: 147.96 Change: -0.99
Read more →Open: 149.39 Close: 148.78 Change: -0.61
Read more →Open: 152.46 Close: 149.06 Change: -3.4
Read more →Open: 152.01 Close: 153.64 Change: 1.63
Read more →Open: 148.12 Close: 148.32 Change: 0.2
Read more →Open: 147.02 Close: 146.69 Change: -0.33
Read more →Open: 148.97 Close: 147.73 Change: -1.24
Read more →Open: 149.92 Close: 150.85 Change: 0.93
Read more →Open: 141.43 Close: 141.9 Change: 0.47
Read more →Open: 138.84 Close: 142.19 Change: 3.35
Read more →Open: 132.93 Close: 133.5 Change: 0.57
Read more →Open: 136.15 Close: 135.28 Change: -0.87
Read more →Open: 136.7 Close: 138.64 Change: 1.94
Read more →Open: 138.72 Close: 137.56 Change: -1.16
Read more →Open: 143.86 Close: 145.11 Change: 1.25
Read more →Open: 149.0 Close: 147.85 Change: -1.15
Read more →Open: 150.84 Close: 152.98 Change: 2.14
Read more →Open: 162.59 Close: 162.41 Change: -0.18
Read more →Open: 179.74 Close: 178.85 Change: -0.89
Read more →Open: 177.26 Close: 178.09 Change: 0.83
Read more →Open: 175.83 Close: 175.75 Change: -0.08
Read more →Open: 174.35 Close: 174.79 Change: 0.44
Read more →Open: 165.85 Close: 163.91 Change: -1.94
Read more →Open: 165.27 Close: 164.4 Change: -0.87
Read more →Open: 164.44 Close: 165.39 Change: 0.95
Read more →Open: 161.75 Close: 162.04 Change: 0.29
Read more →Open: 162.75 Close: 162.4 Change: -0.35
Read more →Open: 162.27 Close: 163.64 Change: 1.37
Read more →Open: 154.05 Close: 154.56 Change: 0.51
Read more →Open: 153.29 Close: 154.94 Change: 1.65
Read more →Open: 153.0 Close: 153.42 Change: 0.42
Read more →Open: 154.74 Close: 154.04 Change: -0.7
Read more →Open: 143.41 Close: 144.15 Change: 0.74
Read more →Open: 138.36 Close: 138.3 Change: -0.06
Read more →Open: 141.89 Close: 141.2 Change: -0.69
Read more →Open: 138.77 Close: 138.93 Change: 0.16
Read more →Open: 146.16 Close: 144.73 Change: -1.43
Read more →Open: 148.95 Close: 147.96 Change: -0.99
Read more →Open: 146.49 Close: 148.24 Change: 1.75
Read more →Open: 153.89 Close: 153.49 Change: -0.4
Read more →Open: 148.39 Close: 146.96 Change: -1.43
Read more →Open: 147.02 Close: 146.69 Change: -0.33
Read more →Open: 149.71 Close: 150.16 Change: 0.45
Read more →Open: 148.97 Close: 147.73 Change: -1.24
Read more →Open: 144.48 Close: 148.85 Change: 4.37
Read more →Open: 143.1 Close: 143.72 Change: 0.62
Read more →Open: 134.8 Close: 136.58 Change: 1.78
Read more →Open: 133.47 Close: 135.05 Change: 1.58
Read more →Open: 137.3 Close: 135.92 Change: -1.38
Read more →Open: 133.71 Close: 136.87 Change: 3.16
Read more →Open: 145.47 Close: 144.9 Change: -0.57
Read more →Open: 147.41 Close: 146.83 Change: -0.58
Read more →Open: 151.07 Close: 149.25 Change: -1.82
Read more →Open: 147.97 Close: 150.85 Change: 2.88
Read more →